Clozapine rechallenge after myocarditis [1]

Australian and New Zealand Journal of Psychiatry

Volumn 35, Issue 2, 2001, Pages 249-

  Reid, P ^a   McArthur, M ^a   Pridmore, S ^a  

^a ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL;

ADULT; CASE REPORT; CONTROLLED STUDY; ELECTROCARDIOGRAM; HUMAN; HYPERSALIVATION; HYPOTENSION; LETTER; MALE; MEDICAL DECISION MAKING; MYOCARDITIS; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; VERTIGO;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; MALE; MYOCARDITIS; SCHIZOPHRENIA;

EID: 0035032483     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2001.0884a.x     Document Type: Letter

References (4)

1. Myocarditis and cardiomyopathy associated with clozapine
2. Myocarditis - A controversial disease
3. Clozapine-induced extrinsic allergic alveolitis
4. Causality assessment of adverse drug effects: When is rechallenge ethically acceptable?